caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1821040544

Mary Flood

Internal MedicineNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Mary Flood's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL107573
Jose Dizon
Clinical Cardiac Electrophysiology · New York, NY
34205
Gregory Pearson
Diagnostic Radiology · Hudson, OH
27235
Robert Conenello
Podiatry · Orangeburg, NY
2336
MONTEFIORE NYACK HOSPITAL2065
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
2068
Sherelle Laifer-Narin
Diagnostic Radiology · New York, NY
1455
James Reiffel
Internal Medicine · New York, NY
1443
Stuart Bentley-Hibbert
Diagnostic Radiology · Valhalla, NY
1386
Elizabeth Hecht
Diagnostic Radiology · Philadelphia, PA
1253
AUSTIN, JOHN1146
Jeffrey Newhouse
Diagnostic Radiology · New York, NY
1154
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
945
Beneficiaries
—
Total drug cost
$75K
Distinct drugs
38
Brand share
12.2%
Top prescribed drugs
Omeprazole75 claims
Furosemide66 claims
Quetiapine Fumarate64 claims
Amlodipine Besylate50 claims
Montelukast Sodium41 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.